Similarly, an adjusted analysis by Kim et al. showed that development of thyroid dysfunction was significantly associated with longer PFS and OS in NSCLC patients treated with anti-PD-1 antibodies (147), suggesting that endocrine irAEs may be representative of the potential immune reaction to tumor cells. Here, PDCD1 is linked to non-small cell lung carcinoma.